From: Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study
Characteristic | |
---|---|
Number of subjects (N) | 57 |
Gender [N (%) female] | 38 (66.7%) |
Race [N (%) self-reported white] | 40 (70.2%) |
Ethnicity [N (%) self-reported Hispanic/Latino] | 14 (24.5%) |
Age [years, mean+/−SD, (range)] | 14.78 +/− 3.12 (5, 18) |
Disease duration [days, mean+/−SD] | 564.04 +/− 440.69 |
Disease modifying therapy (DMT) [N (%)] | 38 (66.7%) |
Time on DMT [days, mean +/− SD, (range)]* | 206.57 +/− 207.76 (0, 702) |
EDSS [mean +/− SD, (range)]** | 1.1 +/− 1.0 (0, 4.0) |
EDSS [median, (range)]** | 1.0 (0.4.0) |
T2 lesion count [mean +/− SD, (range)]^ | 24.30+/−19.68 (1,113) |
T2 lesion total volume [mm3, mean +/− SD, (range)]^ | 10489.28+/− 12477.55 (55.37, 61472.37) |
GD + lesion count [mean +/− SD, (range)]† | 1.85 +/− 5.84, (0, 32) |
GD + lesion volume [mm3, mean +/− SD, (range)]†† | 710+/− 1739, (60, 7536) |